PESTRIN, MARTA
PESTRIN, MARTA
Adjuvant chemotherapy: which patient? What regimen?
2013 Turner N; Biganzoli L; Malorni L; Migliaccio I; Moretti E; Pestrin M; Sanna G; Siclari O; Di Leo A.
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines
2009 Mazzanti, R; Solazzo, M; Fantappie, O; D'Amico, M; Sassoli, C; Tani, A; Cipriani, G; Bogani, C; Pestrin, M; Formigli, L
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing
2015 Salvianti, F.; Rotunno, G.; Galardi, F. ; De Luca, F. ; Pestrin, M.; Vannucchi, A.M.; Di Leo, A.; Pazzagli, M.; Pinzani, P;
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
2015 Pestrin, Marta; Salvianti, Francesca; Galardi, Francesca; De Luca, Francesca; Turner, Natalie; Malorni, Luca; Pazzagli, Mario; Di Leo, Angelo; Pinzani, Pamela
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer
2016 De Luca, Francesca; Rotunno, Giada; Salvianti, Francesca; Galardi, Francesca; Pestrin, Marta; Gabellini, Stefano; Simi, Lisa; Mancini, Irene; Vannucchi, Alessandro Maria; Pazzagli, Mario; Di Leo, Angelo; Pinzani, Pamela
Taxanes in the elderly: Can we gain as much and be less toxic?
2009 Biganzoli L; Licitra S; Moretti E; Pestrin M; Zafarana E; Di Leo A
The continued evidence from overviews: What is the clinical utility?
2013 Turner N; Biganzoli L; Malorni L; Migliaccio I; Moretti E; Pestrin M; Sanna G; Siclari O; Di Leo A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adjuvant chemotherapy: which patient? What regimen? | 2013 | Turner N; Biganzoli L; Malorni L; Migliaccio I; Moretti E; Pestrin M; Sanna G; Siclari O; Di Leo A. | |
| Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines | 2009 | Mazzanti, R; Solazzo, M; Fantappie, O; D'Amico, M; Sassoli, C; Tani, A; Cipriani, G; Bogani, C; Pestrin, M; Formigli, L | |
| Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing | 2015 | Salvianti, F.; Rotunno, G.; Galardi, F. ; De Luca, F. ; Pestrin, M.; Vannucchi, A.M.; Di Leo, A.; Pazzagli, M.; Pinzani, P; | |
| Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients | 2015 | Pestrin, Marta; Salvianti, Francesca; Galardi, Francesca; De Luca, Francesca; Turner, Natalie; Malorni, Luca; Pazzagli, Mario; Di Leo, Angelo; Pinzani, Pamela | |
| Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer | 2016 | De Luca, Francesca; Rotunno, Giada; Salvianti, Francesca; Galardi, Francesca; Pestrin, Marta; Gabellini, Stefano; Simi, Lisa; Mancini, Irene; Vannucchi, Alessandro Maria; Pazzagli, Mario; Di Leo, Angelo; Pinzani, Pamela | |
| Taxanes in the elderly: Can we gain as much and be less toxic? | 2009 | Biganzoli L; Licitra S; Moretti E; Pestrin M; Zafarana E; Di Leo A | |
| The continued evidence from overviews: What is the clinical utility? | 2013 | Turner N; Biganzoli L; Malorni L; Migliaccio I; Moretti E; Pestrin M; Sanna G; Siclari O; Di Leo A |